CIPLA.NS
Price:
$1511
Market Cap:
$1.22T
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Cipla Lim...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1996-01-01
Stock Exchange
NSE
Ticker
CIPLA.NS
According to Cipla Limited’s latest financial reports and current stock price. The company's current PE Ratio is 22.43. This represents a change of 0.33% compared to the average of 22.36 of the last 4 quarters.
The mean historical PE Ratio of Cipla Limited over the last ten years is 29.76. The current 22.43 PE Ratio has changed 7.44% with respect to the historical average. Over the past ten years (40 quarters), CIPLA.NS's PE Ratio was at its highest in in the March 2018 quarter at 64.89. The PE Ratio was at its lowest in in the March 2017 quarter at -192.52.
Average
29.76
Median
28.53
Minimum
22.04
Maximum
47.37
Discovering the peaks and valleys of Cipla Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.68%
Maximum Annual PE Ratio = 47.37
Minimum Annual Increase = -37.60%
Minimum Annual PE Ratio = 22.04
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 22.14 | -24.59% |
| 2024 | 29.36 | 13.19% |
| 2023 | 25.94 | -20.52% |
| 2022 | 32.63 | 19.39% |
| 2021 | 27.33 | 24.01% |
| 2020 | 22.04 | -20.47% |
| 2019 | 27.71 | -15.71% |
| 2018 | 32.88 | -30.59% |
| 2017 | 47.37 | 56.68% |
| 2016 | 30.23 | -37.60% |
The current PE Ratio of Cipla Limited (CIPLA.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
25.81
5-year avg
27.48
10-year avg
29.76
Cipla Limited’s PE Ratio is less than Torrent Pharmaceuticals Limited (59.56), less than Torrent Pharmaceuticals Limited (59.56), greater than Dr. Reddy's Laboratories Limited (18.07), greater than Zydus Lifesciences Limited (19.04), greater than Dr. Reddy's Laboratories Limited (18.07), greater than Zydus Lifesciences Limited (19.04), greater than Lupin Limited (21.94), greater than Lupin Limited (21.94), less than Apollo Hospitals Enterprise Limited (61.27), less than Apollo Hospitals Enterprise Limited (61.27),
| Company | PE Ratio | Market cap |
|---|---|---|
| 59.56 | $1.27T | |
| 59.56 | $1.27T | |
| 18.07 | $1.06T | |
| 19.04 | $936.55B | |
| 18.07 | $1.06T | |
| 19.04 | $937.61B | |
| 21.94 | $950.07B | |
| 21.94 | $948.79B | |
| 61.27 | $1.02T | |
| 61.27 | $1.02T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cipla Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cipla Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cipla Limited's PE Ratio?
How is the PE Ratio calculated for Cipla Limited (CIPLA.NS)?
What is the highest PE Ratio for Cipla Limited (CIPLA.NS)?
What is the 3-year average PE Ratio for Cipla Limited (CIPLA.NS)?
What is the 5-year average PE Ratio for Cipla Limited (CIPLA.NS)?
How does the current PE Ratio for Cipla Limited (CIPLA.NS) compare to its historical average?